# @yalesph on Instagram

- **Type:** Image
- **Original URL:** https://www.instagram.com/p/CKovNOSsK-m
- **Gondola URL:** https://gondola.cc/posts/12511942-yalesph-instagram
- **Thumbnail:** https://img.gondola.cc/tr:w-,h-,fo-auto/thumbnails/391908584f.jpg
- **Posted:** 2021-01-29T17:01:32.000+00:00
- **Account Owner:** Yale School of Public Health (@yalesph) — https://gondola.cc/yalesph

## Caption

There's some great news from today's Johnson & Johnson one-dose coronavirus vaccine trial results, explains Yale School of Public Health & yaleschoolofmed immunologist Akiko Iwasaki. 
.
.
.
.

Image description: tweet from Prof. Akiko Iwasaki that says "A single-shot J&J Janssen COVID19 vaccine phase 3 results summarized in one table. Great news! Imagine being 💯 protected from death 28 days after a single shot, and 💯 protected from severe disease after 49 days - against all variants." and a table showing the Efficacy of Johnson & Johnson Single-Shot Jansen COVID-19 Vaccine Phase 3 ENSEMBLE Trial. It shows the vaccine is 72% effective for moderate & severe disease after 28 days in the U.S., 66% in Latin American and 57% in South Africa (95% B.1.351 variant). For all variants, it's 85% effective for severe disease and 100% effective for death after 28 days and 100% effective for severe disease after 49 days.

#JohnsonAndJohnson #Vaccines #CovidVaccines #CovidNews #ThisIsPublicHealth #GoodNews

## Stats

- **Views:** 0
- **Likes:** 198
- **Shares:** 0
- **Comments:** 2

## Tags

covidnews, covidvaccines, thisispublichealth, johnsonandjohnson, goodnews, vaccines

---
Copyright (c) Gondola